19,829 results match your criteria Unstable Angina

Glucose lowering does not necessarily reduce cardiovascular risk in type 2 diabetes.

World J Cardiol 2022 Apr;14(4):266-270

Department of Cardiology, University Hospital of Larissa, Larissa 41110, Greece.

Diabetes mellitus (DM) is a health condition characterized by glucose dysregulation and affects millions of people worldwide. The presentation of heart failure in diabetic cardiomyopathy extends over a wide phenotypic spectrum, commencing from asymptomatic, subclinical structural abnormalities to severely symptomatic biventricular dysfunction with increased mortality risk. Similarly, the spectrum of systolic dysfunction in diabetic-induced heart failure is diverse. Read More

View Article and Full-Text PDF

Early Initiation of Evolocumab Treatment in Chinese Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

Clin Ther 2022 May 14. Epub 2022 May 14.

Department of Cardiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Electronic address:

Purpose: Evolocumab has been shown to improve cardiovascular outcomes in patients with stable atherosclerotic disease. Whether this benefit persists in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) remains undetermined. This study aimed to evaluate the efficacy and safety of the early initiation of evolocumab in Chinese patients with ACS undergoing PCI. Read More

View Article and Full-Text PDF

High expression of lncRNA PELATON serves as a risk factor for the incidence and prognosis of acute coronary syndrome.

Sci Rep 2022 May 16;12(1):8030. Epub 2022 May 16.

Department of Laboratory Medicine, Sun Yat-sen University Affiliated Zhongshan Hospital, Zhongshan, 528403, Guangdong Province, China.

Atherosclerosis is the primary origin of acute coronary syndrome (ACS) diseases. Previous studies have shown that lncRNA plaque-enriched long noncoding RNA in atherosclerotic macrophage regulation (lncRNA PELATON) is a specific lncRNA in macrophage nuclei. This study aims to identify serum lncRNA PELATON as a biomarker for assessing the incidence and prognosis of ACS. Read More

View Article and Full-Text PDF

The potential population health impact of treating REDUCE-IT eligible US adults with Icosapent Ethyl.

Am J Prev Cardiol 2022 Jun 28;10:100345. Epub 2022 Apr 28.

MedStar Health Research Institute, Georgetown University, Washington, DC.

Objective: To explore the population health impact of treating all US adults eligible for the Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial (REDUCE-IT) with icosapent ethyl (IPE), we estimated (1) the number of ASCVD events and healthcare costs that could be prevented; and (2) medication costs.

Methods: We derived REDUCE-IT eligible cohorts in (1) the National Health and Nutrition Examination Surveys (NHANES) 2009-2014 and (2) the Optum Research Database (ORD). Population sizes were obtained from NHANES and observed first event rates (composite of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, unstable angina requiring hospitalization, or coronary revascularization) were estimated from the ORD. Read More

View Article and Full-Text PDF

Clinical applications of high-sensitivity troponin testing: from diagnosis to prognosis.

Can J Cardiol 2022 May 12. Epub 2022 May 12.

Department of Internal Medicine, University of Manitoba, Winnipeg, Canada; Section of Cardiology, University of Manitoba, Winnipeg, Canada.

High-sensitivity cardiac troponin (hs-cTn) is critical in the diagnosis of acute coronary syndrome. However, it can also inform risk of cardiovascular events and mortality. Patients with unstable angina and normal-range hs-cTn have a very favorable short-term prognosis and do not appear to suffer increased risk of cardiovascular events and mortality. Read More

View Article and Full-Text PDF

Adherence to Prescribing Guideline-Directed Medical Therapy at Hospital Discharge in Subjects With Acute Coronary Syndrome, and the Relationship With Mortality.

Cureus 2022 Apr 10;14(4):e24000. Epub 2022 Apr 10.

College of Pharmacy, King Saud University, Riyadh, SAU.

Introduction The use of guideline-directed medical therapy (GDMT) after acute coronary syndrome (ACS) is associated with a significant reduction in mortality; however, suboptimal prescribing of these therapies has been reported. This study aims to determine adherence to prescribing GDMT in subjects with ACS at hospital discharge and to measure the relationship between this adherence and one-year mortality. Methods A retrospective cohort study was conducted on adults admitted with an ACS. Read More

View Article and Full-Text PDF

Clinical value and expression of Homer 1, homocysteine, S-adenosyl-l-homocysteine, fibroblast growth factors 23 in coronary heart disease.

BMC Cardiovasc Disord 2022 May 12;22(1):215. Epub 2022 May 12.

Department of Cardiology, Renmin Hospital, Hubei University of Medicine, No. 39 Chaoyang Middle Road, Shiyan, 442000, Hubei, China.

Background: This study aimed to explore clinical value and expression of Homer 1, S-adenosyl-l-homocysteine (SAH), homocysteine (Hcy), fibroblast growth factors (FGF) 23 in coronary heart disease (CHD).

Methods: From March 2020 to April 2021, a total of 137 patients with CHD and 138 healthy subjects who came to our hospital for physical examination and had no cardiovascular disease were retrospectively enrolled, and they were assigned to the CHD group and the control group, respectively. Patients in the CHD group were divided into stable angina pectoris (SAP) group (n = 48), unstable angina pectoris (UAP) group (n = 46), and acute myocardial infarction (AMI) group (n = 43) according to clinical characteristics for subgroup analysis. Read More

View Article and Full-Text PDF

[Evaluation of Accuracy and Influencing Factors for Diagnosis of Two Chronic Diseases by Primary Healthcare Providers in Sichuan Rural Areas Based on Standardized Patients].

Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2022 Apr;44(2):213-220

Department of Health Behavior and Social Medicine,West China School of Public Health and West China Fourth Hospital, Sichuan University,Chengdu 610041,China.

Objective We used standardized patients to evaluate the accuracy and explore the influencing factors of the diagnosis of unstable angina pectoris and type 2 diabetes by primary healthcare providers in Sichuan rural areas,aiming to provide a scientific basis for improving the diagnosis accuracy of primary healthcare providers for the two chronic diseases. Methods A multi-stage stratified random cluster sampling method was adopted to select 100 villages from 50 townships in 5 districts/counties in Zigong city,Sichuan province. General and internal medicine practioners who were on duty on the survey day were enrolled in the survey. Read More

View Article and Full-Text PDF

Effect of a low dose of empagliflozin on short-term outcomes in type 2 diabetics with acute coronary syndrome after percutaneous coronary intervention.

Saudi Med J 2022 May;43(5):458-464

From the Department of Cardiology (Adel, Jorfi, Mombeini, Fazeli), from the Atherosclerosis Research Center (Adel, Jorfi, Mombeini), and from the Department of Internal Medicine (Rashidi), Ahvaz Jundishapur University of Medical Sciences, Imam Khomeini Hospital, Ahvaz, Iran.

Objectives: To study the effects of low dose of empagliflozin on improving outcomes in diabetic patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI).

Methods: This double-blind controlled clinical trial was carried out on 93 diabetic patients (56 males and 37 females, mean age of 56.55 years) with ACS who underwent PCI at 2 university teaching hospitals in 2020, Ahvaz, Iran. Read More

View Article and Full-Text PDF

Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons.

Cardiology 2022 May 10. Epub 2022 May 10.

Background Unstable angina (UA) is a component of acute coronary syndrome that is only occasionally included in primary composite endpoints in clinical cardiovascular trials. The aim of this paper is to elucidate the potential benefits and disadvantages of including UA in such contexts. Summary UA comprises <10% of patients with acute coronary syndromes in contemporary settings. Read More

View Article and Full-Text PDF

Remnant Cholesterol Predicts Risk of Cardiovascular Events in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries.

J Am Heart Assoc 2022 May 10;11(10):e024366. Epub 2022 May 10.

Department of Cardiology Fuwai HospitalNational Center for Cardiovascular DiseasesChinese Academy of Medical Sciences and Peking Union Medical College Beijing China.

Background Remnant cholesterol (RC) has been reported to promote atherosclerotic cardiovascular disease. Yet little is known regarding the RC-related residual risk in patients with myocardial infarction (MI) with nonobstructive coronary arteries. Methods and Results A total of 1179 patients with MI with nonobstructive coronary arteries were enrolled and divided according to median level of RC calculated as non-high-density lipoprotein cholesterol minus low-density lipoprotein cholesterol. Read More

View Article and Full-Text PDF

Prognostic Value of Plasma Cold-Inducible RNA-Binding Protein in Patients with Acute Coronary Syndrome.

Dis Markers 2022 27;2022:6119601. Epub 2022 Apr 27.

Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

Background: Cold-inducible RNA-binding protein (CIRP) is a proinflammatory cytokine. The Global Registry of Acute Coronary Events (GRACE) risk score has been widely applied in risk stratification in patients with acute coronary syndrome (ACS). We aimed to investigate the prognostic value of CIRP in ACS patients and its incremental prognostic performance on top of GARCE score. Read More

View Article and Full-Text PDF

A case report of pseudoaneurysm of coronary artery within a month of percutaneous coronary intervention.

Eur Heart J Case Rep 2022 May 21;6(5):ytac175. Epub 2022 Apr 21.

Department of Cardiology, Meditrina Hospital, Ambala 133001, Haryana, India.

Background: Coronary artery pseudoaneurysms (PSAs) are uncommon and have poorly understood natural history. Unlike true aneurysms, PSAs do not have all the three layers of the vessel in the aneurysmal wall. The PSAs are most commonly seen after an overzealous percutaneous coronary intervention (PCI) which causes damage to the vessel wall. Read More

View Article and Full-Text PDF

Incidence, diagnoses and outcomes of ambulance attendances for chest pain: A population-based cohort study.

Ann Epidemiol 2022 May 2. Epub 2022 May 2.

Department of Cardiology, The Alfred Hospital, Melbourne, Victoria, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia; The Baker Institute, Melbourne, Victoria, Australia. Electronic address:

Aims: Non-traumatic chest pain is one of the most common reasons for calls for emergency assistance and places a significant burden on health services. This study aimed to determine age- and sex-specific incidences, diagnoses, and outcomes of patients with chest pain attended by paramedics using a large population-based sample.

Methods: Consecutive emergency medical services (EMS) attendances for non-traumatic chest pain in Victoria, Australia from January 2015 to June 2019 were included. Read More

View Article and Full-Text PDF

Left Ventricular Diverticulum Mimicking Ventricular Septal Defect During Acute Coronary Syndrome: A Case Report.

Cureus 2022 Apr 28;14(4):e24553. Epub 2022 Apr 28.

Cardiology, Instituto Cardiovascular del Cesar, Valledupar, COL.

Left ventricular diverticulum is a rare cardiac congenital anomaly. It is believed to be caused by the impaired development of the endocardial tube during the fourth week of embryologic development. It contains endocardium, myocardium, and pericardium and displays normal contraction. Read More

View Article and Full-Text PDF

Inhibitory role of recombinant neorudin on canine coronary artery thrombosis.

Pharmacol Res Perspect 2022 Jun;10(3):e00956

Beijing Institute of Radiation Medicine, Beijing, China.

The anticoagulant application is an effective treatment modality for cardiovascular diseases such as coronary heart disease, unstable angina pectoris, and myocardial infarction. In this study, the antithrombotic effect of recombinant neorudin (EPR-hirudin, EH) was evaluated using a canine model of coronary artery thrombosis. A canine model with platelet thrombosis in the left circumferent branch of the coronary artery was designed using Folt's method, and the anti-thrombus activity of EH was investigated. Read More

View Article and Full-Text PDF

Identification of patients with acute myocardial infarction based on coronary CT angiography: the value of pericoronary adipose tissue radiomics.

Eur Radiol 2022 May 4. Epub 2022 May 4.

Department of Radiology, Fourth Affiliated Hospital of Harbin Medical University, No. 37, YiYuan Street, NanGang District, Harbin, 150001, HeiLongJiang Province, China.

Objective: To determine whether radiomics analysis of pericoronary adipose tissue (PCAT) captured by coronary computed tomography angiography (CCTA) could discriminate acute myocardial infarction (MI) from unstable angina (UA).

Methods: In a single-center retrospective case-control study, patients with acute MI (n = 105) were matched to patients with UA (n = 105) and all patients were randomly divided into training and validation cohorts with a ratio of 7:3. Fat attenuation index (FAI) and PCAT radiomics features selected by Max-Relevance and Min-Redundancy (mRMR) and least absolute shrinkage and selection operator (LASSO) around the proximal three major epicardial coronary vessels (LAD [left anterior descending artery], LCx [left circumflex artery], and RCA [right coronary artery]) were used to build logistic regression models. Read More

View Article and Full-Text PDF

C5a receptor inhibitor avacopan in immunoglobulin A nephropathy-an open-label pilot study.

Clin Kidney J 2022 May 24;15(5):922-928. Epub 2022 Jan 24.

ChemoCentryx, San Carlos, CA, USA.

Background: Improvement of proteinuria as a marker for disease activity is associated with a better renal outcome in immunoglobulin A nephropathy (IgAN). Complement is an effector pathway in IgA-mediated kidney injury. Avacopan, a selective C5a receptor inhibitor, has previously shown efficacy in anti-neutrophil cytoplasmic antibody-associated vasculitis. Read More

View Article and Full-Text PDF

Prognostic significance of hypertriglyceridemia in patients at high and very high cardiovascular risk depending on the concentration of high-sensitivity C-reactive protein.

Endocr Metab Immune Disord Drug Targets 2022 Apr 27. Epub 2022 Apr 27.

Department of Internal Medicine, South-Ural State Medical University, Chelyabinsk, Russiac.

Background: It has been established that an increase in triglyceride-rich lipoprotein levels is associated with the development of systemic low-grade inflammation. Data on the prognostic role of hypertriglyceridemia (HTG) dependent on the state of low-grade inflammation are limited.

Objective: The study's objective was to evaluate the predictive value of mild-to-moderate HTG (2. Read More

View Article and Full-Text PDF

Establishing a robotic-assisted PCI program: experiences at a large tertiary referral center.

Heart Vessels 2022 Apr 29. Epub 2022 Apr 29.

Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.

Robotic-assisted percutaneous coronary interventions (rPCI) have proven feasible and safe while reducing radiation exposure for the operator. Recently, rPCI systems have been refined to facilitate the treatment of complex lesions. The aim of the current study was to evaluate challenges and opportunities of establishing an rPCI program at a tertiary referral center. Read More

View Article and Full-Text PDF

New steps in acute coronary syndrome and antihyperlipidemic treatment: Determination of statins and metabolites by liquid chromatography tandem mass spectrometry.

Biomed Chromatogr 2022 Apr 29:e5390. Epub 2022 Apr 29.

Department of Biochemistry, Selcuk University Faculty of Medicine, Konya, Turkey.

Our aim in this study was to develop a validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the measurement of atorvastatin, rosuvastatin and their major metabolites, and furthermore to evaluate patients' adherence to statin therapy and to investigate the effect of statin therapy on various hematological and biochemical parameters. A simple protein precipitation was performed for the extraction of analytes and the extracted samples were injected directly. The levels of drugs and their metabolites were measured by the validated method in a total of 210 patients diagnosed with unstable angina pectoris (USAP), ST-elevation myocardial infarction (STEMI) or non-ST-elevation myocardial infarction (NSTEMI). Read More

View Article and Full-Text PDF

Implications of elevated troponin on time-to-surgery in non-ST elevation myocardial infarction (NIHR Health Informatics Collaborative: TROP-CABG study).

Int J Cardiol 2022 Apr 27. Epub 2022 Apr 27.

NIHR Imperial Biomedical Research Centre, Imperial College London and Imperial College Healthcare NHS Trust, Hammersmith Hospital, London W12 0HS, UK.

Implications of elevated troponin on time-to-surgery in non-ST elevation myocardial infarction(NIHR Health Informatics Collaborative:TROP-CABG study). Benedetto et al. BACKGROUND: The optimal timing of coronary artery bypass grafting (CABG) in patients with non-ST elevation myocardial infarction (NSTEMI) and the utility of pre-operative troponin levels in decision-making remains unclear. Read More

View Article and Full-Text PDF

Thin-Cap Fibroatheroma Rather Than Any Lipid Plaques Increases the Risk of Cardiovascular Events in Diabetic Patients: Insights From the COMBINE OCT-FFR Trial.

Circ Cardiovasc Interv 2022 May 29;15(5):e011728. Epub 2022 Apr 29.

Department Medical University of Silesia, Katowice, Poland (M.R.-D., P.G., W.W., E.K.).

Background: Autopsy studies have established that thin-cap fibroatheromas (TCFAs) are the most frequent cause of fatal coronary events. In living patients, optical coherence tomography (OCT) has sufficient resolution to accurately differentiate TCFA from thick-cap fibroatheroma (ThCFA) and not lipid rich plaque (non-LRP). However, the impact of OCT-detected plaque phenotype of nonischemic lesions on future adverse events remains unknown. Read More

View Article and Full-Text PDF

Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction.

J Am Coll Cardiol 2022 05;79(17):1660-1671

Department of Medicine, Baylor College of Medicine, Houston, Texas, USA; Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA.

Background: REDUCE-IT was a double-blind trial that randomized 8,179 statin-treated patients with controlled low-density lipoprotein cholesterol and moderately elevated triglycerides to icosapent ethyl (IPE) or placebo. There was a significant reduction in the primary endpoint, including death from cardiovascular (CV) causes. The specific impact of IPE among patients with prior myocardial infarction (MI) was unknown. Read More

View Article and Full-Text PDF

Effects of Different Types of Pathogenic Variants on Phenotypes of Familial Hypercholesterolemia.

Front Genet 2022 11;13:872056. Epub 2022 Apr 11.

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.

It has been shown that pathogenic variants are associated with poor clinical outcomes in patients with familial hypercholesterolemia (FH). However, data on the effect of different types of pathogenic variants on FH phenotype is limited. We retrospectively investigated the associations between genotypes and phenotypes, including low-density lipoprotein (LDL) cholesterol level and the occurrence of major adverse cardiac events (MACEs), defined as cardiovascular death, myocardial infarction, unstable angina, or coronary artery revascularization, in patients with FH (N = 1,050, male/female = 490/560). Read More

View Article and Full-Text PDF

Plasma Quantitative Lipid Profiles: Identification of CarnitineC18:1-OH, CarnitineC18:2-OH and FFA (20:1) as Novel Biomarkers for Pre-warning and Prognosis in Acute Myocardial Infarction.

Front Cardiovasc Med 2022 11;9:848840. Epub 2022 Apr 11.

Medical Research Center and Department of Cardiology, Yue Bei People's Hospital, Shantou University Medical College, Shaoguan, China.

This study was aimed to determine the association between potential plasma lipid biomarkers and early screening and prognosis of Acute myocardial infarction (AMI). In the present study, a total of 795 differentially expressed lipid metabolites were detected based on ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS). Out of these metabolites, 25 lipid metabolites were identified which showed specifical expression in the AMI group compared with the healthy control (HC) group and unstable angina (UA) group. Read More

View Article and Full-Text PDF

Event Rates and Risk Factors for Recurrent Cardiovascular Events and Mortality in a Contemporary Post Acute Coronary Syndrome Population Representing 239 234 Patients During 2005 to 2018 in the United States.

J Am Heart Assoc 2022 May 27;11(9):e022198. Epub 2022 Apr 27.

Cardiovascular Division Brigham and Women's Hospital Boston MA.

Background Patients with acute coronary syndrome (ACS) are recognized by guidelines as remaining at high risk for adverse outcomes. Evidence from contemporary, representative ACS populations in a clinical practice setting is necessary to identify subgroups and strategies for improving patient outcomes. We aimed to describe event rates and risk factors in an ACS population over prolonged follow-up for cardiovascular end points. Read More

View Article and Full-Text PDF

The Comparative Risk of Serious Adverse Events With Tofacitinib and TNF Inhibitors in Patients With Ulcerative Colitis: The Korean Experience as Revealed by a National Database.

J Korean Med Sci 2022 Apr 25;37(16):e123. Epub 2022 Apr 25.

Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Tofacitinib is an oral, small-molecule Janus kinase inhibitor approved in South Korea for the treatment of moderate to severe ulcerative colitis (UC) on May 1, 2019. However, safety data are lacking. We investigated the incidence of serious adverse events (SAEs) in patients with UC using tofacitinib from the National Health Insurance Service database. Read More

View Article and Full-Text PDF

Prediction of Hidden Coronary Artery Disease Using Machine Learning in Patients With Acute Ischemic Stroke.

Neurology 2022 Apr 25. Epub 2022 Apr 25.

Department of Neurology, Yonsei University College of Medicine, Seoul, Korea

Background And Objectives: A machine learning technique for identifying hidden coronary artery disease (CAD) might be useful. We developed and validated machine learning models to predict patients with hidden CAD and assess long-term outcomes in patients with acute ischemic stroke.

Methods: Multidetector coronary computed tomography was performed for patients without known history of CAD. Read More

View Article and Full-Text PDF